Evaluating the Anti-Migratory Effect of Fucoxanthin in Human Cisplatin-Resistant Ovarian Cancer Cells
Authors:
Open Access
- 1 March 2024
- journal article
- Published by Apex Publishing in Journal of Advances in Medical and Biomedical Research
- Vol. 32 (151) , 135-143
Abstract
Background & Objective: Ovarian cancer ranks among the most prevalent gynecologic cancers in women with the majority of patients experiencing a recurrent type and developing treatment resistance. Resistance to chemotherapy drugs has been observed to trigger epithelial-mesenchymal transition (EMT), which leads to the acquisition of metastatic properties. Thus, targeting the molecular ...Keywords
This publication has 36 references indexed in Scilit:
- Epithelial ovarian cancer: Review articleCancer Treatment and Research Communications, 2022
- Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to GefitinibJournal of Ethnopharmacology, 2021
- Role of Oct4–Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cellsMolecular Biology Reports, 2020
- Glucosamine reverses drug resistance in MRP2 overexpressing ovarian cancer cellsEuropean Journal of Pharmacology, 2020
- Enrichment of cancer stem‐like cells by the induction of epithelial‐mesenchymal transition using lentiviral vector carrying E‐cadherin shRNA in HT29 cell lineJournal of Cellular Physiology, 2019
- Inhibition of two gastric cancer cell lines induced by fucoxanthin involves downregulation of Mcl-1 and STAT3Human Cell, 2017
- Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma CellsNeurochemical Research, 2016
- Fucoxanthin induces apoptosis in human cervical cancer cell line HeLa via PI3K/Akt pathwayTumor Biology, 2014
- EMT, the cytoskeleton, and cancer cell invasionCancer and Metastasis Reviews, 2009
- The NF-κB Transcription Factor Pathway as a Therapeutic Target in Cancer: Methods for Detection of NF-κB Activity2009